CAF-derived LIF induces nasopharyngeal carcinoma tumor growth [42], promotes the migration and invasion of tumor cells in oropharyngeal carcinomas and melanoma [43,44], stimulates angiogenesis in colon cancer [45], and induces chemoresistance in esophageal squamous cell carcinoma [46]. This evidence concerns the gene LIF and neoplasm.